Jordana Joy, Editor

Raman Bhakhri, OD, FAAO, gives tips for identifying the root cause of optic neuritis.

Rueff, OD, PhD, FAAO, stated during her presentation that optometrists are not taking full advantage of their opportunities to suggest contact lenses to their patients with presbyopia.

Johnson & Johnson has announced new data on its Acuvue Oasys Max 1-Day for Astigmatism contact lenses that demonstrated higher end-of-day comfort when compared to Dailies Total1 for Astigmatism.

New interim data demonstrate that more than half of children wearing DOT lenses experienced no clinically meaningful myopia progression over 18 months.

Catch up on the top stories in optometry during the week of September 29-October 3.

The latest in drug and technology developments and updates from September 2025.

Jeffrey Walline, OD, PhD, said that the growing amount of CE sessions available is what sets the annual Academy meeting apart from other conferences.

Thomas A. Albini, MD; Rahul Tonk, MD, MBA; Alison Bozung, OD, FAAO; and Joseph Allen, OD, FAAO, Dipl ABO, weigh in on what they gained from the conference.

Mark Bullimore, PhD, MCOptom, FAAO, like other ODs, is anxiously awaiting further clinical trial results.

Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, will be joined by a handful of colleagues to discuss the latest in retina in Boston, Massachusetts, from October 8 to 11.

Commercial product shipments will be initiated for patients in October through LENZ’s ePharmacy partner, and the product is anticipated to be available in commercial locations such as retail pharmacies by the middle of the fourth quarter of this year.

Thomas Albini, MD, shares his insights about common cases and the triaging process for patients with ocular trauma.

Catch up on the top stories in optometry during the week of September 22-September 26.

Mark Bullimore, MCOptom, PhD, FAAO, gave a presentation on myopia management alongside Vishakha Thakrar, OD, FAAO, FSLS, at the conference.

Rahul Tonk, MD, MBA, outlines a session he gave alongside Joseph Allen, OD, FAAO, Dipl ABO, at EyeCon 2025.

The lens works to slow the progression of myopia in children aged 6 to 12 years at the initiation of treatment.

The “chip-on-eye” platform works by mimicking the flow of ocular fluids through the endothelial wall.

Diana Canto-Sims, OD, did the digging on private label eyewear companies so you don't have to.

The Delaying the Onset of Nearsightedness Until Treatment (DONUT) study will be the first of its kind in the US.

Much like the rest of the world, the prevalence of myopia in children in the UK is only growing, having more than doubled in the past 50 years.

Catch up on the top stories in optometry during the week of September 15-September 19.

IPV is defined as physical violence, sexual violence, stalking, or psychological aggression that is committed by a current or former spouse or dating partners.

The loans can be used for practice expansion and renovations, purchases of existing practices, funding for retinal imaging equipment, and more.

The country aims to ensure that more than 95% of patients with diabetes receive timely retinal examinations.

The drops are formulated to target bacteria that cause infections such as bacterial conjunctivitis, otitis externa, and swimmer’s ear.

CLI Visionaries will be discussing these initial findings during Vision Expo West in the “Shifting Focus: How the Next Generation Sees Contact Lens Wear and Eye Care” panel.

The study compared visual, refractive, and patient-reported outcomes following implantation of enVista Envy and the enVista monofocal intraocular lens (IOL) in patients undergoing cataract surgery.

The lens will be available to order on September 17 in the US.

The lesion area growth was reduced by more than 50% in its first human clinical trial of K8.

Catch up on the top stories in optometry during the week of September 8-September 12.